240 related articles for article (PubMed ID: 35516002)
41. FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms.
Azzam SK; Alsafar H; Sajini AA
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409166
[TBL] [Abstract][Full Text] [Related]
42. FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis.
Zhao X; Yang Y; Sun BF; Shi Y; Yang X; Xiao W; Hao YJ; Ping XL; Chen YS; Wang WJ; Jin KX; Wang X; Huang CM; Fu Y; Ge XM; Song SH; Jeong HS; Yanagisawa H; Niu Y; Jia GF; Wu W; Tong WM; Okamoto A; He C; Rendtlew Danielsen JM; Wang XJ; Yang YG
Cell Res; 2014 Dec; 24(12):1403-19. PubMed ID: 25412662
[TBL] [Abstract][Full Text] [Related]
43. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.
Hu Y; Gong C; Li Z; Liu J; Chen Y; Huang Y; Luo Q; Wang S; Hou Y; Yang S; Xiao Y
Mol Cancer; 2022 Feb; 21(1):34. PubMed ID: 35114989
[TBL] [Abstract][Full Text] [Related]
44. N
Xu K; Mo Y; Li D; Yu Q; Wang L; Lin F; Kong C; Balelang MF; Zhang A; Chen S; Dai Q; Wang J
Ther Adv Chronic Dis; 2020; 11():2040622320916024. PubMed ID: 32426101
[TBL] [Abstract][Full Text] [Related]
45. ALKBH5 facilitates CYP1B1 mRNA degradation via m6A demethylation to alleviate MSC senescence and osteoarthritis progression.
Ye G; Li J; Yu W; Xie Z; Zheng G; Liu W; Wang S; Cao Q; Lin J; Su Z; Li D; Che Y; Fan S; Wang P; Wu Y; Shen H
Exp Mol Med; 2023 Aug; 55(8):1743-1756. PubMed ID: 37524872
[TBL] [Abstract][Full Text] [Related]
46. Morphine-Driven m6A Epitranscriptomic Neuroadaptations in Primary Cortical Cultures.
Dabrowski KR; Daws SE
Mol Neurobiol; 2024 May; ():. PubMed ID: 38780720
[TBL] [Abstract][Full Text] [Related]
47. Promotion of the resistance of human oral epithelial cells to herpes simplex virus type I infection via N6-methyladenosine modification.
Xu J; Qi Y; Ju Q
BMC Oral Health; 2023 Feb; 23(1):121. PubMed ID: 36814204
[TBL] [Abstract][Full Text] [Related]
48. Targeted mRNA demethylation in Arabidopsis using plant m6A editor.
Fang R; Chen X; Shen J; Wang B
Plant Methods; 2023 Aug; 19(1):81. PubMed ID: 37559087
[TBL] [Abstract][Full Text] [Related]
49. Cell Differentiation and Aging Lead To Up-Regulation of FTO, While the ALKBH5 Protein Level Was Stable During Aging but Up-Regulated During in vitro-Induced Cardiomyogenesis.
Krejčí J; Arcidiacono OA; Čegan R; Radaszkiewicz K; Pacherník J; Pirk J; Pešl M; Fila P; Bártová E
Physiol Res; 2023 Aug; 72(4):425-444. PubMed ID: 37795886
[TBL] [Abstract][Full Text] [Related]
50. Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m
Zhang L; Su X
Cell Oncol (Dordr); 2022 Jun; 45(3):355-365. PubMed ID: 35579750
[TBL] [Abstract][Full Text] [Related]
51. Decreased Peripheral Blood
Luo Q; Fu B; Zhang L; Guo Y; Huang Z; Li J
Dis Markers; 2020; 2020():8193895. PubMed ID: 32685056
[TBL] [Abstract][Full Text] [Related]
52. Dynamic RNA modifications in disease.
Klungland A; Dahl JA
Curr Opin Genet Dev; 2014 Jun; 26():47-52. PubMed ID: 25005745
[TBL] [Abstract][Full Text] [Related]
53. Discovery of two novel ALKBH5 selective inhibitors that exhibit uncompetitive or competitive type and suppress the growth activity of glioblastoma multiforme.
Takahashi H; Hase H; Yoshida T; Tashiro J; Hirade Y; Kitae K; Tsujikawa K
Chem Biol Drug Des; 2022 Jul; 100(1):1-12. PubMed ID: 35384315
[TBL] [Abstract][Full Text] [Related]
54. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
55. m
Nagaki Y; Motoyama S; Yamaguchi T; Hoshizaki M; Sato Y; Sato T; Koizumi Y; Wakita A; Kawakita Y; Imai K; Nanjo H; Watanabe H; Imai Y; Minamiya Y; Kuba K
Genes Cells; 2020 Aug; 25(8):547-561. PubMed ID: 32449584
[TBL] [Abstract][Full Text] [Related]
56. ALKBH5-Mediated m6A Demethylation of GLUT4 mRNA Promotes Glycolysis and Resistance to HER2-Targeted Therapy in Breast Cancer.
Liu H; Lyu H; Jiang G; Chen D; Ruan S; Liu S; Zhou L; Yang M; Zeng S; He Z; Wang H; Li H; Zheng G; Liu B
Cancer Res; 2022 Nov; 82(21):3974-3986. PubMed ID: 36069931
[TBL] [Abstract][Full Text] [Related]
57. m
Takemoto S; Nakano M; Fukami T; Nakajima M
Biochem Pharmacol; 2021 Nov; 193():114766. PubMed ID: 34536357
[TBL] [Abstract][Full Text] [Related]
58. m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer.
Duan X; Yang L; Wang L; Liu Q; Zhang K; Liu S; Liu C; Gao Q; Li L; Qin G; Zhang Y
Cell Biosci; 2022 May; 12(1):60. PubMed ID: 35568876
[TBL] [Abstract][Full Text] [Related]
59. Identification of m6A-related genes and m6A RNA methylation regulators in pancreatic cancer and their association with survival.
Geng Y; Guan R; Hong W; Huang B; Liu P; Guo X; Hu S; Yu M; Hou B
Ann Transl Med; 2020 Mar; 8(6):387. PubMed ID: 32355831
[TBL] [Abstract][Full Text] [Related]
60. Methylation modifications in eukaryotic messenger RNA.
Liu J; Jia G
J Genet Genomics; 2014 Jan; 41(1):21-33. PubMed ID: 24480744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
